Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Imports Canít Cure Drug Prices
Detroit Free Press, 10-15-04

This article continues the anti-importation refrain, with a twist: it emphasizes the potential job losses for countries that place price controls on drug companies. It notes that Michigan has 12,000 pharmaceutical industry jobs that pay $70,000 on average, and observes that when Germany last year required a 16-percent rebate on all prescription drugs, companies cancelled plans for new plants and pulled jobs to other countries. Bottom line: markets cannot be eliminated, and if revenues are limited in one place companies will avoid the places that limit them.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000